Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature…

Overview of attention for article published in Frontiers in oncology, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 16 X posts from 16 X users, with an upper bound of 51,584 followers.

RT @EGFRResisters: Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small…

RT @EGFRResisters: Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small…

RT @EGFRResisters: Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small…

RT @EGFRResisters: Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.